{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:07:45Z","timestamp":1758046065913,"version":"3.44.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ab.2022.114830","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T12:41:14Z","timestamp":1659789674000},"page":"114830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Refolding and characterization of a diabody against Pfs25, a vaccine candidate of Plasmodium falciparum"],"prefix":"10.1016","volume":"655","author":[{"given":"Deepak K.","family":"Jagannath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwathi","family":"Valiyaparambil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vysakh K.","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjunath A.","family":"Hurakadli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelagandan","family":"Kamariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alifia C.","family":"Jafer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chhaya","family":"Patole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabyasachi","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3008-0350","authenticated-orcid":false,"given":"Anirudha","family":"Lakshminarasimhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11230-004-6354-6","article-title":"Plasmodium dominicana n. sp. (plasmodiidae: haemospororida) from tertiary Dominican amber","volume":"61","author":"Poinar","year":"2005","journal-title":"Syst. Parasitol."},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-3305-3-5","article-title":"History of the discovery of the malaria parasites and their vectors","volume":"3","author":"Cox","year":"2010","journal-title":"Parasites Vectors"},{"author":"World malaria report 2020","key":"10.1016\/j.ab.2022.114830_bib3"},{"issue":"6906","key":"10.1016\/j.ab.2022.114830_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"issue":"6906","key":"10.1016\/j.ab.2022.114830_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A proteomic view of the Plasmodium falciparum life cycle","volume":"419","author":"Florens","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ab.2022.114830_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41579-019-0306-2","article-title":"Plasmodium asexual growth and sexual development in the haematopoietic niche of the host","volume":"18","author":"Venugopal","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"issue":"9988","key":"10.1016\/j.ab.2022.114830_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Clinical Trials Partnership Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Rts","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib8","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"issue":"10287","key":"10.1016\/j.ab.2022.114830_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ab.2022.114830_bib10","doi-asserted-by":"crossref","first-page":"e00775","DOI":"10.1128\/IAI.00775-18","article-title":"Transmission-blocking vaccines: old friends and new prospects","volume":"87","author":"Acquah","year":"2019","journal-title":"Infect. Immun."},{"issue":"6168","key":"10.1016\/j.ab.2022.114830_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/333074a0","article-title":"A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains","volume":"333","author":"Kaslow","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ab.2022.114830_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ab.2017.11.009","article-title":"Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate","volume":"542","author":"Lee","year":"2018","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(88)80690-2","article-title":"Structure and function of epidermal growth factor-like regions in proteins","volume":"231","author":"Appella","year":"1988","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nsmb1024","article-title":"The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms","volume":"13","author":"Saxena","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01924-3","article-title":"Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25","volume":"8","author":"Scally","year":"2017","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.ab.2022.114830_bib16","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/emboj\/20.15.3975","article-title":"P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions","volume":"20","author":"Tomas","year":"2001","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2875-4-15","article-title":"Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells?","volume":"4","author":"Baton","year":"2005","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.ab.2022.114830_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-6851(00)00371-6","article-title":"Anopheles gambiae laminin interacts with the P25 surface protein of Plasmodium berghei ookinetes","volume":"112","author":"Vlachou","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.ab.2022.114830_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molbiopara.2007.03.002","article-title":"The surface protein Pvs25 of Plasmodium vivax ookinetes interacts with calreticulin on the midgut apical surface of the malaria vector Anopheles albimanus","volume":"153","author":"Rodr\u00edguez","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0166-6851(89)90134-5","article-title":"Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum","volume":"32","author":"Kaslow","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"issue":"7407","key":"10.1016\/j.ab.2022.114830_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nature11174","article-title":"Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing","volume":"487","author":"Manske","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib22","doi-asserted-by":"crossref","first-page":"18848","DOI":"10.1038\/srep18848","article-title":"Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ab.2022.114830_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163144","article-title":"Safety and immunogenicity of pfs25-EPA\/alhydrogel, a transmission blocking vaccine against Plasmodium falciparum: an open label study in malaria na\u00efve adults","volume":"11","author":"Talaat","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ab.2022.114830_bib24","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51","volume":"3","author":"Wu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2022.114830_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.174.5.1203","article-title":"Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals","volume":"174","author":"Barr","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ab.2022.114830_bib26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1107\/S0907444994001782","article-title":"Crystallization of an intact monoclonal antibody (4B7) against Plasmodium falciparum malaria with peptides from the Pfs25 protein antigen","volume":"50","author":"Stura","year":"1994","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ab.2022.114830_bib27","doi-asserted-by":"crossref","first-page":"E1922","DOI":"10.1073\/pnas.1207738109","article-title":"Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum development","volume":"109","author":"Isaacs","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ab.2022.114830_bib28","first-page":"44","article-title":"Construction of a human functional single-chain variable fragment (scFv) antibody recognizing the malaria parasite Plasmodium falciparum","volume":"44","author":"Prasomrothanakul","year":"2006","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ab.2022.114830_bib29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/432552","article-title":"An anti\u2010chitinase malaria transmission\u2013blocking single\u2010chain antibody as an effector molecule for creating a Plasmodium falciparum\u2013refractory mosquito","volume":"192","author":"Li","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ab.2022.114830_bib30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/CVI.00456-06","article-title":"Single-chain antibody fragment specific for Plasmodium vivax duffy binding protein","volume":"14","author":"Kim","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ab.2022.114830_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(99)00158-9","article-title":"A single-chain antibody fragment specific for the Plasmodium berghei ookinete protein Pbs21 confers transmission blockade in the mosquito midgut","author":"Yoshida","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ab.2022.114830_bib32","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2002-03-0831","article-title":"T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites","volume":"101","author":"Yoshida","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-016-1464-6","article-title":"Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates","volume":"15","author":"Lee","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ab.2022.114830_bib34","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0264-410X(02)00701-6","article-title":"Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials","volume":"21","author":"Zou","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ab.2022.114830_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037179","article-title":"Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission","volume":"7","author":"Gregory","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2022.114830_bib36","doi-asserted-by":"crossref","unstructured":"Farrance C, Chichester J, Musiychuk K, Shamloul M, Rhee A, Manceva S, Jones R, Mamedov T, Sharma S, Mett V et al. Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity. Hum. Vaccine;7:191-198.","DOI":"10.4161\/hv.7.0.14588"},{"key":"10.1016\/j.ab.2022.114830_bib37","doi-asserted-by":"crossref","unstructured":"Kaslow D, Isaacs S, Quakyi I, Gwadz R, Moss B, Keister D. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science;252:1310-1313.","DOI":"10.1126\/science.1925544"},{"key":"10.1016\/j.ab.2022.114830_bib38","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1016\/j.vaccine.2010.08.022","article-title":"Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen","volume":"28","author":"Mlambo","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ab.2022.114830_bib39","article-title":"Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ab.2022.114830_bib40","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/IAI.00306-10","article-title":"Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization","volume":"78","author":"Miyata","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ab.2022.114830_bib41","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1073\/pnas.052706099","article-title":"Natural B-sheet proteins use negative design to avoid edge-to-edge aggregation","volume":"99","author":"Richardson","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2022.114830_bib42","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1073\/pnas.0800459105","article-title":"Correctly folded Pfs48\/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice","volume":"105","author":"Outchkourov","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2022.114830_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/19420862.2014.985933","article-title":"Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle","volume":"7","author":"Zhang","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.ab.2022.114830_bib44","first-page":"1844","article-title":"Engineering disulfide bonds within an antibody","author":"Hagihara","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"key":"10.1016\/j.ab.2022.114830_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20621","article-title":"Tolia N Malaria parasite CelTOS targets the inner leaflet of cell membranes for pore-dependent disruption","volume":"5","author":"Jimah","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ab.2022.114830_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/antib8040048","article-title":"Distinguishing between monomeric scFv and diabody in solution using light and small angle X-ray scattering","volume":"8","author":"L\u00fcdel","year":"2019","journal-title":"Antibodies"},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11980-6","article-title":"Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25","volume":"10","author":"McLeod","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ab.2022.114830_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01927","article-title":"Solubility, stability, and avidity of recombinant antibody fragments expressed in microorganisms","volume":"11","author":"Kang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ab.2022.114830_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/protein\/10.4.423","article-title":"Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero- residue linker a trimer","volume":"10","author":"Kortt","year":"1997","journal-title":"Protein Eng. Des. Sel."},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib50","article-title":"Crystal structures of mono- and bi-specific diabodies and reduction of their structural flexibility by introduction of disulfide bridges at the Fv interface","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ab.2022.114830_bib51","doi-asserted-by":"crossref","first-page":"12918","DOI":"10.1021\/bi9810407","article-title":"A factors influencing the dimer to monomer transition of an antibody single-chain fv fragment","volume":"37","author":"Arndt","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2022.114830_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-2836(02)00403-5","article-title":"Reversible dimer formation and stability of the anti-tumour single-chain fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy","volume":"320","author":"Lee","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2022.114830_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1006\/bbrc.2002.6526","article-title":"Linear correlation between thermal stability and folding kinetics of lysozyme","volume":"291","author":"Cao","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2022.114830_bib54","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1080\/21645515.2016.1171443","article-title":"Salmonella flagellin acted as an effective fusion partner for expression of Plasmodium falciparum surface protein 25 in Escherichia coli","volume":"12","author":"Qian","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"issue":"3","key":"10.1016\/j.ab.2022.114830_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121673","article-title":"Dissecting antibodies with regards to linear and conformational epitopes","volume":"10","author":"Forsstr\u00f6m","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2022.114830_bib56","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/bjc.1998.233","article-title":"Marks J (Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2\/neu","volume":"77","author":"Adams","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ab.2022.114830_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2003.11.007","article-title":"Immunosuppressive properties of anti-CD3 single-chain Fv and diabody","volume":"285","author":"Le Gall","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ab.2022.114830_bib58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/1078-0432.CCR-14-0492","article-title":"CD99 triggering in ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin","volume":"21","author":"Guerzoni","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ab.2022.114830_bib59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ymeth.2018.09.005","article-title":"Structural diversity and flexibility of diabodies","volume":"154","author":"Kwon","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.ab.2022.114830_bib60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/19420862.2019.1603024","article-title":"Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules","volume":"11","author":"Seifert","year":"2019","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib61","doi-asserted-by":"crossref","first-page":"16.16. 11","DOI":"10.1002\/0471142727.mb1606s28","article-title":"Expression and purification of maltose\u2010binding protein fusions","volume":"28","author":"Riggs","year":"1994","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.ab.2022.114830_bib62","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/ac60205a048","article-title":"Determination of molecular weights of proteins by gel filtration of Sephadex","volume":"35","author":"Whitaker","year":"1963","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ab.2022.114830_bib63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1475-2859-10-57","article-title":"Endotoxin-free purification for the isolation of Bovine Viral Diarrhoea Virus E2 protein from insoluble inclusion body aggregates","volume":"10","author":"Cavallaro","year":"2011","journal-title":"Microb. Cell Factories"},{"issue":"1","key":"10.1016\/j.ab.2022.114830_bib64","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1038\/s41598-018-32817-0","article-title":"Human and mouse albumin bind their respective neonatal Fc receptors differently","volume":"8","author":"Nilsen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ab.2022.114830_bib65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ab.2015.11.010","article-title":"Development of a sample preparation method for monitoring correct disulfide linkages of monoclonal antibodies by liquid chromatography-mass spectrometry","volume":"495","author":"Wang","year":"2016","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2022.114830_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(98)01631-7","article-title":"Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression 1","volume":"442","author":"Fukushi","year":"1999","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"2","key":"10.1016\/j.ab.2022.114830_bib67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jb\/mvab049","article-title":"Development of biparatopic bispecific antibody possessing tetravalent scFv-Fc capable of binding to ROBO1 expressed in hepatocellular carcinoma cells","volume":"170","author":"Watanabe","year":"2021","journal-title":"J. Biochem."},{"key":"10.1016\/j.ab.2022.114830_bib68","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.bbapap.2014.07.005","article-title":"Engineering disulfide bonds within an antibody","volume":"1844","author":"Hagihara","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269722002901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269722002901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:36:37Z","timestamp":1757712997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269722002901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":68,"alternative-id":["S0003269722002901"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2022.114830","relation":{},"ISSN":["0003-2697"],"issn-type":[{"type":"print","value":"0003-2697"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refolding and characterization of a diabody against Pfs25, a vaccine candidate of Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2022.114830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114830"}}